References
- World Health Organization. WHO/Europe brief – transgender health in the context of ICD-11. [cited 2021 Mar 8]. 2021a. Available from: https://www.euro.who.int/en/health-topics/health-determinants/gender/gender-definitions/whoeurope-brief-transgender-health-in-the-context-of-icd-11.
- Deutsch MB. Guidelines for the primary and gender-affirming care of transgender and gender nonbinary people. 2016. [cited 2020 Jul 20]. Available from: https://transcare.ucsf.edu/guidelines.
- WPATH. WPATH policy statements: position statement on medical necessity of treatment, sex reassignment, and insurance coverage for transgender and transsexual people in the U.S.A. 2016 Dec 21. [cited 2020 Jul 20]. Available from: https://www.wpath.org/newsroom/medical-necessity-statement.
- Baker KE, Wilson LM, Sharma R, et al. Hormone therapy, mental health, and quality of life among transgender people: a systematic review. J Endocr Soc. 2021;5(4):bvab011. DOI:10.1210/jendso/bvab011.
- Aguayo-Romero RA, Reisen CA, Zea MC, et al. Gender affirmation and body modification among transgender persons in Bogotá, Colombia. Int J Transgend. 2015;16(2):103–115. DOI:10.1080/15532739.2015.1075930.
- Clements-Nolle K, Marx R, Guzman R, et al. HIV prevalence, risk behaviors, health care use, and mental health status of transgender persons: implications for public health intervention. Am J Public Health. 2001;91(6):915–921. DOI:10.2105/ajph.91.6.915.
- Garofalo R, Deleon J, Osmer E, et al. Overlooked, misunderstood and at-risk: exploring the lives and HIV risk of ethnic minority male-to-female transgender youth. J Adolesc Health. 2006;38(3):230–236. DOI:10.1016/j.jadohealth.2005.03.023.
- Sanchez NF, Sanchez JP, Danoff A. Health care utilization, barriers to care, and hormone usage among male-to-female transgender persons in New York City. Am J Public Health. 2009;99(4):713–719. DOI:10.2105/ajph.2007.132035.
- Rotondi NK, Bauer GR, Scanlon K, et al. Nonprescribed hormone use and self-performed surgeries: “do-it-yourself” transitions in transgender communities in Ontario, Canada. Am J Public Health. 2013;103(10):1830–1836. DOI:10.2105/ajph.2013.301348.
- Ahmad S, Hillyard M, Bhatia G, et al. Five year progress and outcome for all patients assessed at the Charing Cross Gender Identity Clinic, London, UK, 2009. EPATH biennial conference “Transgender Health Care in Europe,” Ghent, Belgium; 2015 March.
- de Haan G, Santos G-M, Arayasirikul S, et al. Non-prescribed hormone use and barriers to care for transgender women in San Francisco. LGBT Health. 2015;2(4):313–323. DOI:10.1089/lgbt.2014.0128.
- Ferreira ACG, Coelho LE, Jalil EM, et al. Transcendendo: a cohort study of HIV-infected and uninfected transgender women in Rio de Janeiro, Brazil. Transgend Health. 2019;4(1):107–117. DOI:10.1089/trgh.2018.0063.
- Chhim S, Ngin C, Chhoun P, et al. HIV prevalence and factors associated with HIV infection among transgender women in Cambodia: results from a national Integrated Biological and Behavioral Survey. BMJ Open. 2017;7(8):e015390. DOI:10.1136/bmjopen-2016-015390.
- World Health Organization. Consolidated guideline on self-care interventions for health: sexual and reproductive health and rights. 2019a. [cited 2020 Apr 13]. Available from: https://www.who.int/reproductivehealth/publications/self-care-interventions/en/.
- World Health Organization. WHO self-care interventions for health: Sexual and reproductive health and rights: WEB ANNEX: Global values and preferences survey report. 2019b. [cited 2021 Mar 13]. Available from: https://apps.who.int/iris/bitstream/handle/10665/329989/WHO-RHR-19.24-eng.pdf?ua = 1.
- World Health Organization. UHC compendium: Health interventions for universal health coverage, version 1.2. 2021b. [cited 2021 Feb 25]. Available from: https://www.who.int/universal-health-coverage/compendium.
- World Health Organization. Coronavirus disease (COVID-19) technical guidance: Maintaining essential health services and systems. 2020. [cited 2020 Apr 13]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/maintaining-essential-health-services-and-systems.
- Bishop A. Vulnerability amplified: the impact of the COVID-19 pandemic on LGBTIQ people. OurRight Action International. 2020. cited 2021 Jan 14]. Available from: https://outrightinternational.org/sites/default/files/COVIDsReportDesign_FINAL_LR_0.pdf.
- Equity Australia. LGBTIQ+ communities and COVID-19: a report on the impacts of COVID-19 on Australian LGBTIQ+ communities and building a strong response. 2020. [cited 2021 Mar 23]. Available from: https://equalityaustralia.org.au/covid-report/.
- Center for Disaster Philanthropy. LGBTQ+ communities and disasters. N.d. [cited 2021 Mar 23]. Available from: https://disasterphilanthropy.org/issue-insight/lgbtq-communities-and-disasters/.
- Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. DOI:10.1371/journal.pmed.1000097.
- World Health Organization. WHO handbook for guideline development. 2nd ed. World Health Organization; 2014. Available from: https://apps.who.int/iris/handle/10665/145714.
- Higgins JPT, Thomas J, Chandler J, et al. Cochrane handbook for systematic reviews of interventions, version 6.0. 2019 Jul. [cited 2020 Apr 13]. Available from: https://training.cochrane.org/handbook.
- Kennedy CE, Fonner VA, Armstrong KA, et al. The Evidence Project risk of bias tool: assessing study rigor for both randomized and non-randomized intervention studies. Syst Rev. 2019;8(1):3. DOI:10.1186/s13643-018-0925-0.
- Glick JL, Andrinopoulos KM, Theall KP, et al. “Tiptoeing around the system”: alternative healthcare navigation among gender minorities in New Orleans. Transgen Health. 2018;3(1):118–126. DOI:10.1089/trgh.2018.0015.
- de Andrade CAA, Loureiro AR, de Lima Neto ER, et al. Requisitos de autocuidado de mulheres transexuais em uso de hormônios sexuais segundo teoria de orem [Selfcare requirements of transsexual women using sex hormones, according to the Orem selfcare theory]. Cogitare Enferm. 2018;23(3):e55748. DOI:10.5380/ce.v23i3.55748.
- Metastasio A, Negri A, Martinotti G, et al. Transitioning bodies. The case of self-prescribing sexual hormones in gender affirmation in individuals attending psychiatric services. Brain Sci. 2018;8(5):88. DOI:10.3390/brainsci8050088.
- Do TT, Nguyen ATV. ‘They know better than we doctors do’: providers’ preparedness for transgender healthcare in Vietnam. Health Sociol Rev. 2020;29(1):92–107. DOI:10.1080/14461242.2020.1715814.
- Ferguson L, Fried S, Matsaseng T, et al. Human rights and legal dimensions of self-care interventions for sexual and reproductive health. Br Med J. 2019;365:l1941. DOI:10.1136/bmj.l1941.
- Medline Plus. Testosterone injection. 2019. [cited 2021 Feb 25]. Available from: https://medlineplus.gov/druginfo/meds/a614041.html#:~:text = IMPORTANT%20WARNING%3A&text = Testosterone%20undecanoate%20injection%20(Aveed)%20may,or%20reactions%20can%20be%20treated.
- Spratt DI, Stewart II, Savage C, et al. Subcutaneous injection of testosterone is an effective and preferred alternative to intramuscular injection: demonstration in female-to-male transgender patients. J Clin Endocrinol Metab. 2017;102(7):2349–2355. DOI:10.1210/jc.2017-00359.
- Winter S, Diamond M, Green J, et al. Transgender people: health at the margins of society. Lancet. 2016;388(10042):390–400. DOI:10.1016/S0140-6736(16)00683-8.
- Connell R. Transgender health: on a world scale. Health Sociol Rev. 2021;30(1):87–94. DOI:10.1080/14461242.2020.1868899.
- World Health Organization. WHO consolidated guideline on self-care interventions for health and well-being, version 2.3. 2021c. [cited 2021 Oct 29]. Available from: https://app.magicapp.org/#/guideline/Lr21gL.
- Coleman E, Bockting W, Botzer M, et al. Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7. Int J Transgend. 2012;13(4):165–232. DOI:10.1080/15532739.2011.700873.